Transformer model guides safer dose choices in early drug trials
Transformer-Based Reinforcement Learning for Phase I Dose Allocation
Summary
Finding the right drug dose in early trials is tricky because giving too much can be harmful, and giving too little might not work. The authors created a computer program that learns how to pick doses by looking at past patient reactions and the number of patients tried at each dose. This program uses a special AI model called a Transformer to understand the whole trial situation and then decides whether to increase, keep, or lower the dose. The final decision on the best dose is made using another method to make sure safety is prioritized. Their tests show you can balance being safe and choosing the correct dose, though it doesn't necessarily work better than current methods.
What this means in practice
- •For clinical trial designers: Use Transformer-based reinforcement learning to adaptively select doses with a trade-off between safety and accuracy during early phase trials with varying dose levels.
- •For machine learning engineers in healthcare: Develop AI systems that summarize trial data as token sequences for making dose allocation decisions via learned policies in dose-finding studies.
Tested on simulated data.